MARCH 16, 2018

Company

SOLENO THERAPEUTICS INC

Filed

March 16, 2018

Accession Number

0001013594-18-000224

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →